Library / Laws / 115th Congress / House Bills / H.R. 6478
H.R. 6478
To enhance competition for prescription drugs by increasing the ability of the Department of Justice and Federal Trade Commission to enforce existing antitrust laws regarding biologic and biosimilar products, and for other purposes.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2018-07-23 | 6.7K | ⠃⠗⠋ |